Targeting mitochondrial dysfunction in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) - A clinical audit

International Journal of Clinical and Experimental Medicine

Volumn 6, Issue 1, 2013, Pages 1-15

  Myhill, Sarah ^a   Booth, Norman E ^b   McLaren Howard, John ^c  

^a Llangunllo Powys   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Acumen   (United Kingdom)

Author keywords

Adenosine triphosphate (ATP); Cellular energetics; Chronic fatigue syndrome; Mitochondrial dysfunction; Myalgic encephalomyelitis; Nutrition; Oxidative phosphorylation

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ADULT; AGED; ARTICLE; CHELATION THERAPY; CHRONIC FATIGUE SYNDROME; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; DIET SUPPLEMENTATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EATING HABIT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL AUDIT; REST; SAUNA; SLEEP QUALITY; WORK;

EID: 84870330099     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Booth NE, Myhill S and McLaren-Howard J. Mitochondrial Dysfunction and the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Int J Clin Exp Med 2012; 5: 208-220.
2. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG and Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953-959.
3. Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, Staines D, Powles ACP, Speight N, Vallings R, Bateman L, Baumgarten-Austrheim B, Bell DS, Carlo-Stella N, Chia J, Darragh A, Jo D, Lewis D, Light AR, Marshall-Gradisbik S, Mena I, Mikovits JA, Miwa K, Murovska M, Pall ML and Stevens S. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med 2011; 270: 327-338.
4. Myhill S, Booth NE and McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med 2009; 2: 1-16.
5. Wu T-L, Zhang D, Chia J-H, Tsao K-C, Sun C-F and Wu JT. Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. Clin Chim Acta 2002; 321: 77-87.
6. Brand MD and Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem J 2011; 435: 297-312.
7. Peckerman A, Lamanca JJ, Dahl KA, Chemitiganti R, Qureishi B and Natelson BH. Abnormal impedance cardiography predicts symptom severity in chronic fatigue syndrome. Amer J Med Sci 2003; 326: 55-60.
8. Streeten D, Thomas D and Bell DS. The Roles of Orthostatic Hypotension, Orthostatic Tachycardia, and Subnormal Erythrocyte Volume in the Pathogenesis of the Chronic Fatigue Syndrome. Amer J Med Sci 2000; 320: 1-8.
9. Hollingsworth KG, Hodgson T, MacGowan GA, Blamire AM and Newton JL. Impaired Cardiac Function in Chronic Fatigue Syndrome measured using Magnetic Resonance Cardiac Tagging. J Intern Med 2012; 271: 264-270.
10. Hurwitz BE, Coryell VT, Parker M, Martin P, La-Perriere A, Klimas NG, Sfakianakis GN and Bilsker MS. Chronic fatigue syndrome: illness severity, sedentary lifestyle, blood volume and evidence of diminished cardiac function. Clin Sci 2010; 118: 125-135.
11. Miwa K and Fujita M. Small Heart With Low Cardiac Output for Orthostatic Intolerance in Patients With Chronic Fatigue Syndrome. Clin Cardiol 2011; 34: 782-786.
12. Yoshiuchi K, Farkas J and Natelson BH. Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. Clin Physiol Funct Imaging 2006; 26: 83-86.
13. Marieb EN. Essentials of Human Anatomy and Physiology. Pearson Education, 2009.
14. Puddu P, Puddu GM, Galletti L, Cravero E and Muscari A. Mitochondrial Dysfunction as an Initiating Event in Atherogenesis: A Plausible Hypothesis. Cardiology 2005; 103: 137-141.
15. Anthony H, Birtwistle S, Eaton K and Maberly J. Environmental Medicine in Clinical Practice. Br Soc Allergy and Environmental Medicine, 2002.
16. Fosslien E. Mitochondrial Medicine-Molecular Pathology of Defective Oxidative Phosphorylation. Ann Clin Lab Sci 2001; 31: 25-67.
17. Orsucci D, Filosto M, Siciliano G and Mancuso M. Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction. Nutr Rev 2009; 67: 427-438.
18. Werbach MR. Nutritional Strategies for Treating Chronic Fatigue Syndrome. Altern Med Rev 2000; 5: 93-108.
19. Alraek T, Lee MS, Choi TY, Cao H and Liu J. Complementary and alternative medicine for patients with chronic fatigue syndrome: a systematic review. BMC Complement Altern Med 2011; 11: 87.
20. Myhill S. Diagnosing and treating chronic fatigue syndrome. Knighton: Sarah Myhill Ltd. , 2012. (last accessed 2012-08-09).
21. Turner MR and Talbot K. Functional vitamin B12 deficiency. Pract Neurol 2009; 9: 37-45.
22. Matsushita K, Masuda A and Tei C. Efficacy of Waon Therapy for Fibromyalgia. Inter Med 2008; 47: 1473-1476.
23. Beever R. Far-infrared saunas for treatment of cardiovascular risk factors: Summary of published evidence. Can Fam Physician 2009; 55: 691-696.
24. Crinnion W. Sauna as a valuable clinical tool for cardiovascular, autoimmune, toxicant-induced and other chronic health problems. Altern Med Rev 2011; 16: 215-225.
25. Marriage B, Clandinin MT and Glerum DM. Nutritional cofactor treatment in mitochondrial disorders. J Amer Diet Assoc 2003; 103: 1029-1038.
26. Marriage BJ, Clandinin MT, Macdonald IM and Glerum DM. Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders. Mol Genet Metab 2004; 81: 263-272.
27. Teitelbaum J, Jandrain J and McGrew R. Treatment of Chronic Fatigue Syndrome and Fybromyalgia with D-Ribose-An Open-label Multicenter Study. Open Pain J 2012; 5: 32-37.
28. Howard A and Arroll M. The Application of Integral Medicine in the Treatment of Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome. J Integral Theory & Practice 2011; 6: 25-40.
29. Perrin R. The Perrin Technique. London: Hammersmith Press, 2007.
30. White PD, Goldsmith KA, Johnson AL, Potts L, Walwyn R, DeCesare JC, Baber HL, Burgess M, Clark LV, Cox DL, Bavinton J, Angus BJ, Murphy G, Murphy M, O'Dowd H, Wilks D, McCrone P, Chalder T and Sharpe M. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 2011; 377: 823-836.
31. Goudsmit EM, Nijs J, Jason LA and Wallman KE. Pacing as a strategy to improve energy management in myalgic encephalomyelitis/chronic fatigue syndrome: a consensus document. Disability and Rehabilitation 2012; 34: 1140-1147.
32. Twisk FN and Maes M. A review on cognitive behavioural therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME)/ chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS. Neuroendocrinol Lett 2009; 30: 284-299.
33. Kindlon T. Reporting of Harms Associated with Graded Exercise Therapy and Cognitive Behavioural Therapy in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome. Bull IACFS/ME 2011; 19: 59-111.
34. Dowsett EG and Colby J. Long-term sickness absence due to ME/CFS in UK schools: an epidemiological study with medical and educational implications. J Chronic Fatigue Syndr 1997; 3: 29-42.
35. Crawley EM, Emond AM and Sterne JAC. Unidentified Chronic Fatigue Syndrome/myalgic encephalomyelitis (CFS/ME) is a major cause of school absence: surveillance outcomes from school-based clinics. BMJ Open 2011; 1: e000252.
36. Pall ML. Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome. Med Hypotheses 2000; 54: 115-125.
37. Zeevalk GD, Bernard LP, Song C, Gluck M and Ehrhart J. Mitochondrial inhibition and oxidative stress: Reciprocating players in neurodegeneration. Antioxid Redox Signal 2005; 7: 1117-1139.
38. Golomb BA. Oxidative Stress and Mitochondrial Injury in Chronic Multisystem Conditions:From Gulf War Illness to Autism Spectrum Disorder. Available from Nature Precedings 2012.
39. Shungu DC, Weiduschat N, Murrough JW, Mao X, Pillemer S, Dyke JP, Medow MS, Natelson BH, Stewart JM and Mathew SJ. Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed 2012; 25: 1073-1087.
40. Nishihara K. Disclosure of the major causes of mental illness-mitochondrial deterioration in brain neurons via opportunistic infection. J Biol Phys & Chem 2012; 12: 11-18.